GlassScriptPhysician profile
David Sanders
NPI 1831373075
$566.32
in general payments reported to CMS, 2019-2025
10 companies · $197 in 2025
The $197 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2021: $20.16 · 2022: $14.06 · 2023: $17.48 · 2024: $186 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $137.81 | 2024-2025 | Farapulse, Watchman Flx, Watchman Access System |
| Atricure, INC. | $86.43 | 2024-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Avanos Medical | $84.50 | 2024 | On-Q* Pump and Accessories |
| Mallinckrodt Enterprises LLC | $72.76 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $59.08 | 2024-2025 | Exparel, Iovera |
| Daiichi Sankyo INC. | $41.24 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.08 | 2023-2024 | Lifevest |
| Glaxosmithkline, LLC. | $20.16 | 2021 | |
| Merck Sharp & Dohme LLC | $18.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.